Tresa Roebuck-Spencer to Aged
This is a "connection" page, showing publications Tresa Roebuck-Spencer has written about Aged.
Connection Strength
0.186
-
Initial clinical validation of an embedded performance validity measure within the automated neuropsychological metrics (ANAM). Arch Clin Neuropsychol. 2013 Nov; 28(7):700-10.
Score: 0.055
-
Assessing change with the Automated Neuropsychological Assessment Metrics (ANAM): issues and challenges. Arch Clin Neuropsychol. 2007 Feb; 22 Suppl 1:S79-87.
Score: 0.034
-
Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients. Arch Clin Neuropsychol. 2018 Sep 01; 33(6):655-675.
Score: 0.019
-
Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients. Clin Neuropsychol. 2018 Aug - Oct; 32(7):1193-1225.
Score: 0.019
-
Test-retest reliability and practice effects for the ANAM General Neuropsychological Screening battery. Clin Neuropsychol. 2018 04; 32(3):479-494.
Score: 0.018
-
Validation of ANAM for cognitive screening in a mixed clinical sample. Appl Neuropsychol Adult. 2018 Jul-Aug; 25(4):366-375.
Score: 0.018
-
Efficacy of the ANAM General Neuropsychological Screening Battery (ANAM GNS) for detecting neurocognitive impairment in a mixed clinical sample. Clin Neuropsychol. 2013; 27(3):376-85.
Score: 0.013
-
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 2006 Aug; 54(8):2505-14.
Score: 0.008